CASP8 and bladder transitional cell carcinoma: Furthermore, the relationship between CASP8, patient survival, TICs, and ICPIs as demonstrated by our data may open new avenues for treatment of BLCA, making CASP8 an attractive therapeutic target (Stupack, 2013).